No takes yet. Share an insight, caveat, or question.
Preclinical study shows that adenosine monophosphate lowers mitochondrial oxygen demand and doubles hypoxic survival in mice, indicating a potential pharmacological strategy for ischemia.
Kondo et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: